Thomas Jordan, MD.Dr. Jordan has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Randomized controlled trials have not been kind to commercial pharmacogenetic panels, but will Genecept’s fate be any different?
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.